Introduction
The centrosome is the major microtubule organization center of animal cells, where it nucleates interphase microtubules responsible for cell polarity and organizes mitotic spindles for the bipolar separation of sister chromatids ( Meraldi and Nigg, 2002 ) . Numerical and structural centrosome aberrations have been implicated in almost all types of cancer cells ( Saunders, 2005 ) . Despite the apparent link between centrosome amplification and cancer, research is still in the early stages of understanding the molecular mechanisms of centrosome regulation and its deregulation in human diseases. Centro some aberrations have been implicated in the generation of multipolar mitotic spindles and chromosomal instability during tumor development and progression ( Saunders, 2005 ) . The proline-directed phosphatase Cdc14 has been extensively studied in budding yeast where, from G1 until early anaphase, Cdc14 is sequestered in an inactive state in the nucleolus ( Shou et al., 1999 ; Visintin et al., 1999 ) . Cdc14 is activated after release from the nucleolus and functions primarily to inactivate Cdk activity at the end of mitosis, thereby allowing reentry into G1 phase ( Stegmeier and Amon, 2004 ) . Cells that lack Cdc14 are unable to exit from mitosis, with defects in both the movement of chromosomes to the spindle poles and the elongation of anaphase spindles ( Higuchi and Uhlmann, 2005 ) . Human cells possess two Cdc14 paralogue, Cdc14A and Cdc14B, identifi ed based on their sequence similarity to the budding yeast Cdc14 ( Li et al., 1997 ) . Studies suggest that Cdc14A and Cdc14B may be deregulated in various cancer cells including mantle cell lymphoma, breast cancer, prostate cancer, and acute myeloid leukemia ( Wong et al., 1999 ; Martinez et al., 2003 ; Ashida et al., 2004 ; Yu et al., 2004 ; Neben et al., 2005 ; Rubio-Moscardo et al., 2005 ) . Recent fi ndings indicate that Cdc14A and Cdc14B may be involved in distinctive cellular functions. Although Cdc14A regulates centrosome separation and cytokinesis Mailand et al., 2002 ) , Cdc14B may participate in the maintenance of nuclear structure ( Nalepa and Harper, 2004 ) , regulation of mitotic exit through SIRT2 ( Dryden et al., 2003 ) , microtubule stability ( Cho et al., 2005 ) , and G1 length through Skp2 ( Rodier et al., 2008 ) . Interestingly, previous studies, including ours, have shown that a fraction of endogenous and GFP-tagged Cdc14B associated with centrosomes ( Nalepa and Harper, 2004 ; Cho et al., 2005 ). Yet, the functional signifi cance of Cdc14B in centrosome cycle regulation has never been explored. Here, we investigate the functional relationship C entrosome duplication is tightly controlled in coordination with DNA replication. The molecular mechanism of centrosome duplication remains unclear. Previous studies found that a fraction of human proline-directed phosphatase Cdc14B associates with centrosomes. However, Cdc14B ' s involvement in centrosome cycle control has never been explored. Here, we show that depletion of Cdc14B by RNA interference leads to centriole amplifi cation in both HeLa and normal human fi broblast BJ and MRC-5 cells. Induction of Cdc14B expression through a regulatable promoter signifi cantly attenuates centriole amplifi cation in prolonged S phasearrested cells and proteasome inhibitor Z-L 3 VS -treated cells. This inhibitory function requires centriole-associated Cdc14B catalytic activity. Together, these results suggest a potential function for Cdc14B phosphatase in maintaining the fi delity of centrosome duplication cycle.
Cdc14B depletion leads to centriole amplifi cation, and its overexpression prevents unscheduled centriole duplication GFP localized in nuclei/nucleoli ( Cho et al., 2005 ) and was absent from the centrosomes in virtually all the interphase cells examined. In contrast, wild-type Cdc14B-GFP (Cdc14B WT -GFP) was found to associate with centrosomes in ‫ف‬ 75% of GFPpositive interphase cells ( Fig. 2 B ) . Although these fi ndings suggest that catalytic activity is essential for Cdc14B centrosomal localization, its perturbation may also inhibit Cdc14B nucleocytoplasmic shuttling ability, which indirectly prevents Cdc14B from reaching centrosomes in interphase cells where the nuclear envelope is still intact. To exclude this possibility, we studied the localization of Cdc14B C314S -GFP at the centrosomes of mitotic cells where the nuclear envelopes have disassembled. As shown in Fig. 2 , no Cdc14B
C314S
-GFP was found to associate between Cdc14B and centriole number control in human cells using both RNA interference and a drug-induced centriole overduplication system.
Results

Cdc14B centrosomal retention requires
Cdc14B phosphatase activity
Cdc14B has been shown to associate with distinctive cellular structures such as the nucleolus, nuclear fi lament, centrosome, and the spindle midzone and midbody Mailand et al., 2002 ; Nalepa and Harper, 2004 ; Cho et al., 2005 ) , and to undergo active nucleocytoplasmic translocation ( Bembenek et al., 2005 ) . To explore the functional signifi cance of centrosomal Cdc14B, we fi rst examined whether centrosomal localization of Cdc14B was cell cycle -dependent using a chicken anti-Cdc14B antibody. After preextraction and fi xation of U2OS cells, immunofl uorescence analysis revealed that Cdc14B partially colocalized with centrin, a marker that stains at the distal lumen of centrioles, in addition to the nucleolar, intracellular bridge ( Fig. 1 A ) and midzone (not depicted) localization previously characterized using other anti-Cdc14B antibodies Mailand et al., 2002 ; Nalepa and Harper, 2004 ; Cho et al., 2005 ) . Depending on the centriole confi guration during different stages of the cell cycle ( Tsou and Stearns, 2006a ; Nigg, 2007 ) , Cdc14B associates with each of the disengaged centrioles in G1 and late M phase but only one of the engaged centrioles in S, G2, and early M phase ( Fig. 1 A ) . Cdc14B-GFP also showed a similar cell cycle -dependent centriole localization pattern (Fig. S1 , available at http://www.jcb .org/cgi/content/full/jcb.200710127/DC1). We believe that the reason we and others previously did not observe centrioleassociated Cdc14B with the rabbit anti-Cdc14B antibodies Cho et al., 2005 ) was that these antibodies might react with epitopes that were not exposed at centrioles under the extraction/fi xation conditions. In fact, Nalepa and Harper ( 2004 ) found that the centrosomal Cdc14B only became visible after Triton X-100 extraction before fi xation using another rabbit anti-Cdc14B antibody. To independently evaluate the centrosomal association of Cdc14B, we purifi ed centrosome fractions from asynchronized HeLa cells by discontinuous sucrose gradient centrifugation according to a published protocol ( Moudjou and Bornens, 1998 ) . Proteins in each fraction were resolved by SDS-PAGE and analyzed by Western blotting. At the expected ‫ف‬ 60% sucrose density, fractions 14 -17 contained the most abundant amounts of ␥ -tubulin, an archetypical centrosomal marker. In parallel, Cdc14B was highly enriched in those ␥ -tubulincontaining centrosomal fractions ( Fig. 1 B , top) . Moreover, when a purifi ed centrosomal fraction (fraction 15) was subject to immunostaining, we found that Cdc14B but not nucleolin, a noncentrosomal protein, stained positive at the purifi ed centrosomes ( Fig. 1 B , bottom) . Together, these data suggest that a fraction of Cdc14B phosphatase specifi cally associates with centrioles.
To investigate whether Cdc14B catalytic activity is required for Cdc14B centrosome localization, we assessed the centrosomal localization of a catalytic " dead " Cdc14B C314S mutant ( Cho et al., 2005 ) . As shown in Fig. 2 (A and B ) , Cdc14B its nucleocytoplasmic shuttling activity and thus supports the possibility that Cdc14B centrosomal localization requires its catalytic activity. We previously demonstrated that the cytoplasmic translocation/microtubule bundling ability of Cdc14B C314S was impaired but restored when an additional mutation (KKIR29-32AAIA, Cdc14B KKIR ) of a potential NLS was introduced to the Cdc14B C314S mutant (KKIR29-32AAIA+C314S, Cdc14B Cho et al., 2005 ) . Interestingly, introduction of this mutation also restored Cdc14B C314S localization to centrosomes ( Fig. 2 ). Because breakdown of the nuclear/cytoplasmic barrier in mitosis did not restore Cdc14B C314S to centrosomes ( Fig. 2 ) , this fi nding indicates that the additional KKIR mutation not only helps Cdc14B C314S regain cytoplasmic translocation but also acts as a gain-of-function mutant that facilitates Cdc14B
C314S to reassociate with centrosomes.
Ablation of Cdc14B leads to centriole amplifi cation
To determine whether Cdc14B plays a role in centrosome cycle regulation, we took a Cdc14B knockdown approach. We fi rst attempted to establish stable cell lines in which endogenous Cdc14B could be conditionally knocked down. In search of siRNA oligos to deplete the endogenous Cdc14B, we found that an oligo corresponding to nucleotide position 1,234 -1,254 relative to the Cdc14B start codon was most effective in ablating Cdc14B expression. We cloned this siRNA oligo into a pSuperiorneo-GFP vector and the resulting plasmid was transfected into TREx HeLa cells to obtain Cdc14B knockdown stable clones. Western blot analysis showed a reduction of endogenous Cdc14B expression in two of the representative clones (clones No. 2 and 3) in the presence of tetracycline ( Fig. 3 A ) . Consistently, real-time quantitative RT-PCR showed that the level of Cdc14B mRNA level was also decreased in these two clones (unpublished data). The same siRNA could also knock down Cdc14B-GFP expression in U2OS Tet-On cells, confi rming the target specifi city of the Cdc14B siRNA ( Fig. 3 A ) . Moreover, immunostaining with the anti-Cdc14B antibody revealed that centrosomal Cdc14B expression was reduced in Cdc14BsiRNA cells ( Fig. S2 A, available at http://www.jcb.org/cgi/content/ full/jcb.200710127/DC1), though the effi ciency of knockdown varied in each cell. Careful examination of those Cdc14B knockdown clones revealed a centriole amplifi cation phenotype ( Fig. 3 , B and C ). In comparison with the parental TREx HeLa and clone No. 1, which did not exhibit any reduction of Cdc14B expression ( Fig. 3 A ) , clones No. 2 and 3 showed two-to threefold increases in the number of cells with more than four centrioles ( Fig. 3 , B and C ) judged by immunostaining with an anticentrin antibody. The centriole number usually ranged from 5 to 20 with the majority around six to eight centrioles per cell. Similar results were obtained ( Fig. S2 B) when ␥ -tubulin was used as a centrosome marker (Fig. S2 C) . To ascertain the specifi city of Cdc14B knockdown phenotype, we tested a Cdc14B siRNA oligo pool (SMARTpool containing four different Cdc14B siRNA oligos) and a small hairpin RNA (shRNA) designated as pSuperCdc14BshRNA-E9, each targeting different regions of Cdc14B mRNA sequences in transient and stable transfection studies, respectively. Western blot analysis confi rmed that both the with mitotic centrosomes (0%, n = 113), whereas Cdc14B WT -GFP associated with a majority (61%, n = 374) of mitotic centrosomes examined. This fi nding suggests that the failure of Cdc14B C314S centrosomal retention is not because of the lack of To determine if the observed supernumerary centrioles may derive from centrosome fragmentation, we carefully evaluated the ␥ -tubulin -decorated centrosomes in HeLa cells transiently transfected with the Cdc14BsiRNA SMARTpool. We found that a majority of the supernumerary centrosomes were clustered together and similar in size ( Fig. 3 E ) . All the supernumerary centrosomes ( n = 105) contained centrin-labeled centrioles and many of the centrioles were in pairs. These data suggest that the supernumerary centrosomes may not arise from centrosome fragmentation.
Examination of TREx-HeLa Cdc14BsiRNA stable cells revealed a slight increase in the number of polyploid cells, such as multinucleate and macronuclear cells (Fig. S3 A, available at http://www.jcb.org/cgi/content/full/jcb.200710127/DC1). siRNA pool and the shRNA specifi cally knocked down Cdc14B but not its Cdc14A paralogue in HeLa cells ( Fig. 3 D , top) . Moreover, knockdown of Cdc14B by both the siRNA pool and shRNA led to a signifi cant accumulation of cells with more than four centrioles in HeLa cells ( Fig. 3 D , bottom) . Although HeLa cells have been widely used for centrosome studies, it is a tumor cell line. To examine the effect of Cdc14B on centrosome cycle control in normal cells, we transfected normal human fi broblast BJ and MRC-5 cells with the Cdc14B siRNA SMARTpool. As shown in Fig. 4 , the centriole amplifi cation phenotype was faithfully reproduced in the normal fi broblast cells depleted of Cdc14B. These results demonstrate that depletion of Cdc14B leads to centrosome amplifi cation in both normal and transformed cells. ( Fig. 5 A , bottom) or mock-transfected U2OS Tet-On cells ( Fig. 5 B ) . Remarkably, this centriole amplifi cation phenotype was signifi cantly attenuated in cells where Cdc14B WT -GFP was at centrioles but not in cells where Cdc14B WT -GFP was not at centrioles ( Fig. 5 A ) . This fi nding was confi rmed in the same sets of cells treated with HU + DOX for 72 h using ␥ -tubulin as a centrosome marker (Fig. S4, A ( Fig. 5 B ) . Together, these results suggest that Cdc14B overexpression suppresses abnormal centriole amplifi cation, and this inhibitory function requires the presence of Cdc14B-GFP at centrioles in the HU-induced centriole overduplication system. Fluorescenceactivated cell sorting analysis revealed that induction of Cdc14B-GFP did not perturb cell cycle progression at the expression level set by the DOX-inducible promoter ( Fig. 5 C ) , which suggests that the inhibition of centriole amplifi cation in HU-arrested cells was not the result of a potential G1 cell cycle arrest.
Cdc14B phosphatase activity is essential to prevent centriole overduplication in prolonged S phase -arrested cells
To investigate whether inhibition of centriole overduplication in HU-arrested U2OS cells requires the presence of active Cdc14B at centrioles, we took advantage of and tested the centriole-bound Macronuclear and multinucleate cells were determined by visual judgment of the sizes (nuclear diameter and area) of DAPI-stained nuclei and the number of nuclei per cell, respectively. It is important to note that among the TREx-HeLa Cdc14BsiRNA stable cells with centriole amplifi cations, only ‫ف‬ 0.2 ( n = 300) were polyploid. Using the same criteria, we were unable to detect any signifi cant increase of polyploid cells in HeLa cells transiently transfected with Cdc14BsiRNA SMARTpool (Fig. S3 B) . In line with this fi nding, fl ow cytometry analysis did not reveal any signifi cant increase of polyploidy in those Cdc14B knockdown cells (Fig. S3 C) . Moreover, none of the Cdc14B-depleted BJ (0%; n = 115) or MRC-5 (0%; n = 74) cells with more than four centrioles were polyploid. Thus, the centriole amplifi cation phenotype in Cdc14B knockdown cells may not be the product of aborted cell division, and the slight increase in the number of polyploid cells in the TREx-HeLa Cdc14BsiRNA stable clones may have evolved during the course of stable clone selection.
Ectopic expression of centriole-associated
Cdc14B inhibits centriole overduplication in prolonged S phase -arrested cells
In certain transformed cells, such as U2OS cells, prolonged S phase arrest by hydroxyurea (HU) causes multiple rounds of centriole duplication in the absence of DNA replication and mitotic division ( Balczon et al., 1995 ; Chang et al., 2003 ) . We therefore used this well-established centriole overduplication system to directly evaluate whether Cdc14B plays a role in the regulation of centriole duplication. For this purpose, we fi rst tested if Cdc14B overexpression could inhibit HU-induced centriole overduplication in the stable doxycycline (DOX)-inducible Cdc14B WT -GFP U2OS Tet-On cells. Based on the localization of Cdc14B WT -GFP at centrioles ( Fig. 2 ) , the Cdc14B WT -GFP -positive cells can be divided into two groups: Cdc14B WT -GFP at centrioles and not at centrioles. This provides an ideal system to directly examine inhibition of centriole duplication and that docking a catalytically inactive Cdc14B-GFP to centrioles is not suffi cient to prevent centriole overduplication.
Inhibition of Z-L 3 VS -induced centriole overduplication requires Cdc14B phosphatase activity
It has been documented that treatment of U2OS cells with a proteasome inhibitor Z-L 3 VS causes multiple daughter centriole growth from a single mother centriole template ( Duensing et al., 2007 ) . This aberrant daughter centriole overduplication requires cyclin E/Cdk2 and Plk4, the known positive regulators of centriole duplication ( Nigg, 2007 ) . We thus used the catalytic dead Cdc14B K & C -GFP mutant as described in Fig. 2 . When the Cdc14B K & C -GFP cells were exposed to HU, the DOX-induced Cdc14B K & C -GFP was unable to block centriole overduplication, whereas the centriole-associated catalytic " active " Cdc14B KKIR mutant ( Fig. 2 ) was as potent as its wild-type counterpart in inhibition of centriole overduplication ( Fig. 5 A ) . Similar results were obtained when the HU-treated cells were examined by ␥ -tubulin staining (Fig. S4, A and B) . Western blot revealed that all the Cdc14B-GFPs were expressed at the comparable level after Dox induction (Fig. S4 C) , indicating that the failure of Cdc14B K & C -GFP to inhibit centriole overduplication was not caused by its expression level. This fi nding strongly argues that Cdc14B phosphatase activity is indispensable for the centrosome splitting ( Meraldi and Nigg, 2001 ) . A similar mechanism may prevail in the regulation of centrosome duplication ( Nigg, 2007 ) . To our knowledge, Cdc14B is the only phosphatase identifi ed as a negative regulator of centrosome duplication, though a recent study shows that another phosphatase, Cdc25B, also regulates centrosome duplication, albeit as a positive regulator ( Boutros et al., 2007 ) . It is possible that Cdc14B may act to keep the centrosomes in check before and/or after centrosome duplication by opposing the activities of Cdk2 and other related kinases required for the initiation of centrosome duplication. It has been demonstrated that mammalian Cdc14s preferentially dephosphorylate Ser/Thr-proline -directed sites of Cdkphosphorylated substrates ( Li et al., 2000 ; Kaiser et al., 2002 ) . Cdk2/cyclin E and A are involved in the initiation of centrosome duplication in cycling cells ( Hinchcliffe et al., 1999 ; Meraldi et al., 1999 ) . In this context, Cdc14B may oppose cyclin A/Cdk2 activity to prevent centrosome reduplication because centrosome duplication terminates at the end of S phase and cyclin A/Cdk2 is still active throughout S phase and early mitosis ( Pagano et al., 1992 ) . Cdc14B may also stabilize Cdk inhibitor 1/Kip1 ( Saito et al., 2004 ) by promoting dephosphorylation-dependent Skp2 degradation ( Rodier et al., 2008 ) , which in turn inhibits Cdk2/ cyclin E activity in G1 to prevent premature centriole duplication. Recent studies suggest that Plk4 plays an important role in triggering procentriole assembly and, thus, uncontrolled activation may impose risks of abnormal procentriole growth ( Habedanck et al., 2005 ) . Under this circumstance, Plk4 activity may call for scrupulous counterbalance by Cdc14B-like phosphatases, though centrosomal substrates of Plk4 and Cdc14B remain unknown and the consensus phosphorylation motif of Plk4 substrates ( Leung et al., 2007 ) may not conform to a typical Ser/Thr-proline motif of Cdc14B substrates. Z-L 3 VS -induced centriole duplication system to evaluate the possibility of Cdc14B as a counterbalancing enzyme of cyclin E/Cdk2 and/or Plk4 in centriole duplication control. In the absence of Cdc14B ( Fig. 6 ) . Moreover, similar to our observation in the HU experiment ( Figs. 5 and S4, A and B) , the centriole-bound catalytic dead Cdc14B K & C mutant failed to prevent Z-L 3 VS -induced centriole overduplication ( Fig. 6 ) , indicating that this inhibition requires Cdc14B catalytic activity. Although additional experiments are required, our study supports the possibility that Cdc14B may counterbalance centrosomal kinases required for centriole overduplication in the Z-L 3 VS induction system.
Discussion
The fi ndings that depletion of Cdc14B leads to centriole amplifi cation and that overexpression of Cdc14B inhibits HU-and Z-L 3 VS -induced centriole overduplication imply that Cdc14B may play a pivotal role in the regulation of centriole duplication cycle. Because catalytic activity of Cdc14B is required to harness centriole overduplication in both HU-and Z-L 3 VS experimental systems, Cdc14B may exert its effect through modulating the phosphorylation status of its substrates, in particular those involved in the control of centrosome duplication. It has been well documented that the activities of centrosome-associated protein kinases, such as Cdk2/cyclin E/A, Plk2, Plk4, calciumcalmodulin kinase II, MpsI, and Zyg-1, are required for centriole duplication in various species and experimental settings including the HU-and Z-L 3 VS -induced centriole overduplication systems ( Matsumoto et al., 1999 ; Meraldi et al., 1999 ; Fisk and Winey, 2001 ; O ' Connell et al., 2001 ; Matsumoto and Maller, 2002 ; Fisk et al., 2003 ; Warnke et al., 2004 ; Habedanck et al., 2005 ; Tsou and Stearns, 2006b ; Duensing et al., 2007 ; Kleylein-Sohn et al., 2007 ) , which suggests that phosphorylation plays an important role for the precise reproduction of centrosomes during the cell cycle ( Tsou and Stearns, 2006a ; Nigg, 2007 ) . Phosphorylation of centrosome-associated proteins such as nucleophosmin/B23, CP110, and Mps1 has been implicated in centrosome duplication control. In particular, phosphorylation of B23 Thr199 by Cdk2/cyclin E and of B23 Thr95 by an unknown kinase dissociates B23 from centrosomes, which in turn allows centrosome duplication or reduplication to occur ( Okuda et al., 2000 ; Budhu and Wang, 2005 ) . Likewise, depletion of CP110 abolishes centrosome reduplication in S phase -arrested cells ( Chen et al., 2002 ) and suppresses Plk4-induced procentriole reduplication ( Habedanck et al., 2005 ) , whereas inactivation of Cdk2 activity abolishes Mps1-dependent centrosome duplication ( Fisk and Winey, 2001 ) . Based on our observation in this study, it is possible that Cdc14B may regulate the centriole duplication cycle by modulating the phosphorylation status of centrosomal proteins such as B23, CP110, and Mps1.
A counterbalance of kinase and phosphatase activities involving Nek2 and PP1 ␣ has been proposed for governing 
Immunofl uorescence
For indirect immunofl uorescence, cells were grown on glass coverslips and fi xed with either paraformaldehyde or cold 100% methanol. The cells were then permeabilized with PBS/0.5% Triton X-100 for 10 min followed by blocking with PBS/1% BSA for 30 min. Centrosomes or centrioles were visualized by immunostaining with antibodies against ␥ -tubulin (GTU-88 [Sigma-Alrich] and C-20 [Santa Cruz Biotechnology, Inc.), pericentrin (Abcam), or centrin (20H5; a gift from J. Salisbury, Mayo Clinic Foundation, Rochester, MN). For visualization of centriole-associated endogenous Cdc14B, cells were treated with or without 10 μ g/ml nocodazole (for better exposure of centrosomal Cdc14B) for 2 h, briefl y extracted with 0.5% Triton X-100 on ice, fi xed with cold 100% methanol, and immunostained with chicken anti-Cdc14B antibody (GenWay Biotech, Inc.). In our hands, methanol fi xation preserved GFP signals and, thus, anti-GFP immunostaining was not used to visualize Cdc14B-GFP fusion proteins in the fi xed cells. Secondary antibodies including Alexa Fluor 488 and 594 donkey anti -mouse and anti -goat and goat anti -rabbit, and anti -chicken IgY antibodies were obtained from Invitrogen. DNA was counterstained by DAPI. Cells were visualized with a 100 × Plan Neofl uar objective (1.30 oil; ϱ /0.17; Carl Zeiss, Inc.) under an epifl uorescence microscope (Axioskop 2; Carl Zeiss Inc). Images were acquired with a charge-coupled device camera (AxioCam HRC; Carl Zeiss, Inc.) controlled by Openlab software (version 3.5; PerkinElmer). For confocal microscopy, images were captured with an HCX-PL/APO 63 X 1.32 oil objective (Leica) under a SP2 laser scanning confocal microscope (Leica) equipped with confocal software (LCS version 2.0; Leica). The coverslips were mounted using PermaFlour Mountant media (Thermo Fisher Scientifi c) and imaging was performed at room temperature. Image processing was performed using Photoshop CS (8.0).
Centrosome fractionation experiments
Centrosomes were prepared from exponentially growing HeLa cells according to a previously published procedure ( Moudjou and Bornens, 1998 ) . In brief, a total of 6 × 10 8 cells were treated with 1 μ g/ml cytochalasin D and 2.2 μ M nocodazole. Cells were lysed in a buffer containing 1 M Hepes, pH 7.2, 0.5% NP-40, 0.5 mM MgCl 2 , 0.1% ␤ -mercaptoethanol, and protease inhibitor cocktail (Roche) and centrifuged at 2,500 g . The resulting supernatant was fi ltered, incubated with 2 U/ml DNase I, and loaded over a 60% sucrose cushion for centrifugation at 10,000 g with a SW28 rotor (Beckman Coulter). Concentrated centrosomes were centrifuged again over a discontinuous gradient containing 70, 50, and 40% sucrose solutions at 75,000 g . A total of 32 fractions were collected from the bottom of the tube. Each fraction was separated by SDS-PAGE. Centrosomeenriched fractions were determined by immunoblotting with anti -␥ -tubulin antibody, and the presence of Cdc14B was judged by immunoblotting with anti-Cdc14B antibody (Invitrogen). For immunofl uorescence analysis of isolated centrosomes, each 10 μ l of fraction 15 was diluted into 4 ml of 10 mM Pipes buffer, pH 7.2, and transferred into a 38.5-ml ultracentrifuge tube (Beckman Coulter) with a specially designed adaptor to fi t to a 15-mm round coverslip. The samples were then subjected to centrifugation at 20,000 g (10,000 rpm) for 20 min with a SW28 rotor followed by fi xation in methanol at Ϫ 20 ° C for 10 min and immunostaining with antibodies against centrin, Cdc14B (GenWay Biotech, Inc.), and nucleolin (4E2; Research Diagnostics, Inc.), respectively. Finally, coverslips were placed in pure ethanol for 2 min at room temperature, air-dried, and mounted with a drop of Permafl our (Thermo Fischer Scientifi c) on a microscope slide. Images were captured as described in the preceding paragraph. Fig. S1 shows that a fraction of Cdc14B-GFP associates with centrioles. Fig. S2 shows the specifi cities of Cdc14B and ␥ -tubulin antibodies, and centrosome amplifi cation in Cdc14B knockdown cells. Fig. S3 shows polyploidy cells in Cdc14BsiRNA stable clones. Fig. S4 shows that Cdc14B catalytic activity is required to prevent HU-induced centrosome overduplication. Online supplemental material is available at http://www.jcb .org/cgi/content/full/jcb.200710127/DC1.
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